JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB243865

Anti-BRD2 antibody [BL-167-2A2]

Be the first to review this product! Submit a review

|

(2 Publications)

Knockout Tested Rabbit Recombinant Monoclonal BRD2 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human BRD2 aa 650 to C-terminus.

View Alternative Names

KIAA9001, RING3, BRD2, Bromodomain-containing protein 2, O27.1.1

5 Images
Immunoprecipitation - Anti-BRD2 antibody [BL-167-2A2] (AB243865)
  • IP

Unknown

Immunoprecipitation - Anti-BRD2 antibody [BL-167-2A2] (AB243865)

BRD2 was immunoprecipitated from 0.5 mg HEK-293T whole cell lysate with ab243865 at 10 µl per reaction Western blot was performed on the immunoprecipitate using ab243865 at 1/1000 dilution. Lane 1 : ab243865 IP in HEK-293T cell lysate.

Lane 2 : Contol IgG in HEK-293T cell lysate.

Detection : Chemiluminescence with an exposure time of 3 minutes.

All lanes:

Immunoprecipitation - Anti-BRD2 antibody [BL-167-2A2] (ab243865)

Predicted band size: 88 kDa

false

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)
  • WB

Lab

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)

False colour image of Western blot : Anti-BRD2 antibody [BL-167-2A2] staining at 1/1000 dilution, shown in green; Mouse Anti-Nucleophosmin antibody [FC82291] (ab10530) loading control staining at 2 ug/mL imaged in ECL. In Western blot, ab243865 was shown to bind specifically to BRD2. A band was observed at 110 kDa in wild-type A549 cell lysates with no signal observed at this size in BRD2 knockout cell line. To generate this image, wild-type and BRD2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent ab133456) and imaged with 20 seconds exposure time. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and HRP conjugated Goat anti-Mouse (H+L) at 1/20000 dilution.

All lanes:

Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution

Lane 1:

Wild-type A549 cytoplasm cell lysate at 20 µg

Lane 2:

Wild-type A549 nuclear cell lysate at 20 µg

Lane 3:

BRD2 knockout A549 C7 cytoplasm cell lysate at 20 µg

Lane 4:

BRD2 knockout A549 C7 nuclear cell lysate at 20 µg

Lane 5:

Wild-type HEK-293T cell lysate at 20 µg

Lane 6:

BRD2 knockout HEK-293T cell lysate at 20 µg

false

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)
  • WB

Lab

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)

Lanes 1-3 : Merged signal (red and green). Green - ab243865 observed at 110 kDa. Red - loading control ab8245 observed at 36 kDa.

ab243865 Anti-BRD2 antibody [BL-167-2A2] was shown to specifically react with BRD2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab267265 (knockout cell lysate ab257191) was used. Wild-type and BRD2 knockout samples were subjected to SDS-PAGE. ab243865 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

BRD2 knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human BRD2 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-brd2-knockout-hek-293t-cell-line-ab267265'>ab267265</a>)

Lane 3:

HeLa cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 88 kDa

Observed band size: 110 kDa

false

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)
  • WB

Supplier Data

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)

All lanes:

Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution

Lane 1:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg

Lane 2:

MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 50 µg

Lane 3:

Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 50 µg

Lane 4:

A549 (Human lung carcinoma cell line) whole cell lysate at 50 µg

Lane 5:

SW620 (Human colon carcinoma cell line) whole cell lysate at 50 µg

Lane 6:

SK-MEL-28 (Human melanoma cell line) whole cell lysate at 50 µg

Lane 7:

Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 50 µg

Secondary

All lanes:

Goat anti-rabbit IgG, HRP conjugated

Predicted band size: 88 kDa

false

Exposure time: 30s

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)
  • WB

Supplier Data

Western blot - Anti-BRD2 antibody [BL-167-2A2] (AB243865)

All lanes:

Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution

Lane 1:

RenCa (Mouse epithelial kidney cell line) whole cell lysate at 50 µg

Lane 2:

NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 50 µg

Lane 3:

C2C12 (Mouse myoblast cell line) whole cell lysate at 50 µg

Secondary

All lanes:

Goat anti-rabbit IgG, HRP conjugated

Predicted band size: 88 kDa

false

Exposure time: 3s

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

BL-167-2A2

Isotype

IgG

Carrier free

No

Reacts with

Human, Mouse

Applications

WB, IP

applications

Immunogen

Synthetic Peptide within Human BRD2 aa 650 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P25440

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p>Use 10μl/0.5mg lysate.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Product details

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

This product is sold under License from Bethyl Laboratories, Inc.

Properties and storage information

Form
Liquid
Purification notes
Recombinant antibody was purified from cell culture supernatant.
Storage buffer
pH: 7.8 - 8.6 Preservative: 0.09% Sodium azide Constituents: 98% Borate buffered saline, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Chromatin reader protein that specifically recognizes and binds histone H4 acetylated at 'Lys-5' and 'Lys-12' (H4K5ac and H4K12ac, respectively), thereby controlling gene expression and remodeling chromatin structures (PubMed : 17148447, PubMed : 17848202, PubMed : 18406326, PubMed : 20048151, PubMed : 20709061, PubMed : 20871596). Recruits transcription factors and coactivators to target gene sites, and activates RNA polymerase II machinery for transcriptional elongation (PubMed : 28262505). Plays a key role in genome compartmentalization via its association with CTCF and cohesin : recruited to chromatin by CTCF and promotes formation of topologically associating domains (TADs) via its ability to bind acetylated histones, contributing to CTCF boundary formation and enhancer insulation (PubMed : 35410381). Also recognizes and binds acetylated non-histone proteins, such as STAT3 (PubMed : 28262505). Involved in inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17 : recognizes and binds STAT3 acetylated at 'Lys-87', promoting STAT3 recruitment to chromatin (PubMed : 28262505). In addition to acetylated lysines, also recognizes and binds lysine residues on histones that are both methylated and acetylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed : 37731000). Specifically binds histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed : 37731000).
See full target information BRD2

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Signal transduction and targeted therapy 8:302 PubMed37582812

2023

CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties.

Applications

Unspecified application

Species

Unspecified reactive species

Mengzhu Lv,Ying Gong,Xuesong Liu,Yan Wang,Qingnan Wu,Jie Chen,Qingjie Min,Dongyu Zhao,Xianfeng Li,Dongshao Chen,Di Yang,Danna Yeerken,Rui Liu,Jinting Li,Weimin Zhang,Qimin Zhan

Cell discovery 9:47 PubMed37156794

2023

BRD4-targeting PROTAC as a unique tool to study biomolecular condensates.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Shi,Yuan Liao,Qianlong Liu,Zhihao Ni,Zhenzhen Zhang,Minglei Shi,Pilong Li,Haitao Li,Yu Rao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com